Hospital
Indiana University Health INC
Indiana University Health INC was paid $75.62M by Medicaid between Jan 2018 and Dec 2024, across 228 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
33Billing provider infoINDIANA UNIVERSITY HEALTH INC
INDIANAPOLIS, IN 46202
INDIANAPOLIS, IN 46202
33aNPI1114958584assigned 07/05/2006
33bProvider typeChildren's Hospital
28Total paid$75.62M
24GClaims467,699
24DCodes billed228
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ALVEY, JENNIFER controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 64,583 | $6.55M | |
| 2019 | 69,039 | $8.99M | |
| 2020 | 47,193 | $6.56M | |
| 2021 | 69,225 | $10.80M | |
| 2022 | 86,071 | $15.17M | |
| 2023 | 73,289 | $14.96M | |
| 2024incomplete | 58,299 | $12.58M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 135,801 | 128,315 | $27.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 46,738 | 43,577 | $9.42M |
| 31622 | 7.8% | 1,911 | 1,696 | $5.93M | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 6.5% | 2,417 | 2,175 | $4.88M |
| 99218 | 3.9% | 5,015 | 2,910 | $2.93M | |
| 76770 | 2.7% | 10,377 | 9,640 | $2.02M | |
| 71046 | Radiologic examination, chest; 2 views | 2.6% | 12,218 | 11,344 | $1.96M |
| 64642 | 2.4% | 1,909 | 1,752 | $1.79M | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.1% | 13,490 | 10,397 | $1.62M |
| 99221 | 2.1% | 2,370 | 2,130 | $1.62M | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 7,062 | 6,291 | $1.25M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.5% | 810 | 726 | $1.13M |
216 more codes
| 94375 | 1.5% | 10,399 | $1.13M | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 4,954 | $1.01M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.1% | 5,009 | $847K |
| 16020 | 1.1% | 3,666 | $805K | |
| J0475 | Injection, baclofen, 10 mg | 1.0% | 625 | $766K |
| 95990 | <1% | 611 | $523K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 2,655 | $500K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 6,461 | $478K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,934 | $472K |
| 92567 | <1% | 8,217 | $451K | |
| 59025 | Fetal non-stress test | <1% | 1,446 | $432K |
| 72082 | <1% | 4,258 | $410K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 703 | $399K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 701 | $373K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 643 | $372K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 68 | $294K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 2,166 | $255K |
| 95700 | <1% | 513 | $241K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,228 | $232K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 26,763 | $179K |
| 31526 | <1% | 815 | $178K | |
| 92604 | <1% | 1,378 | $171K | |
| 51600 | <1% | 179 | $146K | |
| 92555 | <1% | 2,580 | $137K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,281 | $135K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,286 | $134K |
| 80053 | Comprehensive metabolic panel | <1% | 13,525 | $127K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,248 | $114K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 165 | $104K |
| 95951 | <1% | 184 | $100K | |
| 73130 | <1% | 1,891 | $99K | |
| 51784 | <1% | 380 | $97K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 5,124 | $97K |
| 36415 | Collection of venous blood by venipuncture | <1% | 27,619 | $95K |
| 90947 | <1% | 1,530 | $95K | |
| 95716 | <1% | 370 | $91K | |
| 74018 | <1% | 499 | $86K | |
| 72170 | <1% | 1,975 | $82K | |
| 76825 | <1% | 209 | $79K | |
| 51729 | <1% | 86 | $73K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,295 | $64K |
| 76820 | <1% | 890 | $57K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 19 | $56K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,419 | $51K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 483 | $51K |
| L3808 | Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment | <1% | 101 | $46K |
| 90937 | <1% | 422 | $43K | |
| 36591 | <1% | 359 | $41K | |
| 62369 | <1% | 85 | $36K | |
| 16025 | <1% | 127 | $36K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 821 | $33K |
| 72081 | <1% | 658 | $31K | |
| 87503 | <1% | 1,134 | $31K | |
| 77073 | <1% | 615 | $30K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,161 | $27K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,373 | $27K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 798 | $25K |
| 92552 | <1% | 216 | $25K | |
| 64644 | <1% | 54 | $24K | |
| 83970 | <1% | 1,863 | $24K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 135 | $23K |
| 82728 | <1% | 2,772 | $22K | |
| 93325 | <1% | 1,501 | $22K | |
| 97763 | <1% | 382 | $22K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 147 | $20K |
| 82977 | <1% | 2,873 | $19K | |
| 83735 | <1% | 4,430 | $19K | |
| 92602 | <1% | 137 | $18K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 398 | $18K |
| 86923 | <1% | 30 | $17K | |
| 92579 | <1% | 532 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,769 | $16K |
| 73070 | <1% | 382 | $16K | |
| 80348 | <1% | 107 | $16K | |
| 94060 | <1% | 153 | $15K | |
| 85045 | <1% | 4,896 | $15K | |
| 96409 | <1% | 176 | $15K | |
| 92522 | <1% | 82 | $14K | |
| 83550 | <1% | 2,572 | $13K | |
| 31541 | <1% | 29 | $13K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 808 | $13K |
| 83020 | <1% | 920 | $12K | |
| 84100 | <1% | 3,693 | $11K | |
| 83540 | <1% | 2,638 | $10K | |
| 93975 | <1% | 14 | $10K | |
| 87276 | <1% | 907 | $10K | |
| 36430 | <1% | 27 | $9K | |
| 73110 | <1% | 148 | $9K | |
| 81001 | <1% | 3,788 | $9K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 63 | $9K |
| 87275 | <1% | 907 | $8K | |
| 92593 | <1% | 181 | $8K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 46 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 113 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 664 | $8K |
| 92526 | <1% | 81 | $7K | |
| 80061 | Lipid panel | <1% | 692 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 488 | $7K |
| 80069 | <1% | 911 | $6K | |
| 31231 | <1% | 75 | $6K | |
| 81002 | <1% | 2,843 | $6K | |
| 74019 | <1% | 26 | $6K | |
| 97167 | <1% | 38 | $6K | |
| 73090 | <1% | 144 | $6K | |
| 84439 | <1% | 689 | $6K | |
| 80197 | <1% | 491 | $6K | |
| 49452 | <1% | 16 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 572 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 80 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 86 | $5K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 26 | $5K |
| 92587 | <1% | 458 | $5K | |
| 82550 | <1% | 769 | $4K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 34 | $4K |
| 94200 | <1% | 39 | $4K | |
| 85027 | <1% | 1,691 | $4K | |
| 97760 | <1% | 163 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 97 | $4K |
| 96450 | <1% | 20 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,613 | $4K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 15 | $4K |
| 85610 | <1% | 926 | $4K | |
| 86317 | <1% | 34 | $3K | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 166 | $3K |
| 31599 | <1% | 59 | $3K | |
| 97542 | <1% | 65 | $3K | |
| 82784 | <1% | 224 | $3K | |
| 73552 | <1% | 54 | $3K | |
| 85652 | <1% | 953 | $2K | |
| 73080 | <1% | 38 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 15 | $2K |
| 87497 | <1% | 57 | $2K | |
| 36592 | <1% | 24 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 68 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 17 | $2K |
| 83516 | <1% | 235 | $2K | |
| 92553 | <1% | 14 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 13 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 18 | $2K |
| 85730 | <1% | 299 | $2K | |
| 86481 | <1% | 35 | $2K | |
| 86140 | <1% | 331 | $2K | |
| 77075 | <1% | 14 | $2K | |
| 80050 | General health panel | <1% | 14 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 174 | $2K |
| 82570 | <1% | 472 | $2K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 19 | $2K |
| 86357 | <1% | 38 | $1K | |
| 86355 | <1% | 36 | $1K | |
| 96415 | <1% | 15 | $1K | |
| 86003 | <1% | 55 | $1K | |
| 84075 | <1% | 1,240 | $1K | |
| 73590 | <1% | 25 | $1K | |
| 86359 | <1% | 51 | $1K | |
| 80074 | <1% | 30 | $1K | |
| 92592 | <1% | 20 | $974.39 | |
| 81003 | <1% | 518 | $958.87 | |
| 96381 | <1% | 40 | $958.82 | |
| 82248 | <1% | 198 | $953.47 | |
| 84450 | <1% | 1,189 | $940.36 | |
| 77072 | <1% | 45 | $932.49 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 192 | $929.42 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 16 | $926.10 |
| 73610 | <1% | 14 | $922.63 | |
| 86803 | <1% | 263 | $907.68 | |
| 84156 | <1% | 292 | $896.12 | |
| 87400 | <1% | 122 | $879.89 | |
| 80076 | <1% | 111 | $814.09 | |
| 93320 | <1% | 286 | $808.92 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 41 | $765.45 |
| 86850 | <1% | 144 | $689.49 | |
| 73630 | <1% | 14 | $634.50 | |
| 82108 | <1% | 101 | $598.12 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 103 | $558.12 |
| 87340 | <1% | 145 | $527.63 | |
| 82103 | <1% | 46 | $509.00 | |
| 82785 | <1% | 28 | $494.41 | |
| 86706 | <1% | 128 | $489.04 | |
| 86901 | <1% | 159 | $442.09 | |
| 86900 | <1% | 159 | $442.09 | |
| 92595 | <1% | 15 | $415.95 | |
| 94726 | <1% | 18 | $394.98 | |
| 86708 | <1% | 32 | $388.62 | |
| 82810 | <1% | 14 | $346.06 | |
| 80305 | <1% | 27 | $323.43 | |
| 83655 | <1% | 30 | $304.70 | |
| 81025 | <1% | 55 | $303.01 | |
| 86704 | <1% | 104 | $276.83 | |
| 82040 | <1% | 483 | $271.99 | |
| 84520 | <1% | 284 | $260.19 | |
| 94770 | <1% | 25 | $252.33 | |
| 82610 | <1% | 15 | $198.06 | |
| 82104 | <1% | 17 | $154.87 | |
| 83051 | <1% | 21 | $144.94 | |
| 84460 | <1% | 152 | $121.57 | |
| 82247 | <1% | 148 | $105.22 | |
| 84155 | <1% | 156 | $80.60 | |
| 83690 | <1% | 14 | $65.92 | |
| 82330 | <1% | 87 | $55.98 | |
| 82465 | <1% | 14 | $53.26 | |
| 84550 | <1% | 12 | $49.58 | |
| 76937 | <1% | 12 | $42.14 | |
| 85347 | <1% | 25 | $31.90 | |
| 85014 | <1% | 13 | $14.27 | |
| 0064U | 0% | 33 | $0.00 | |
| C1769 | Guide wire | 0% | 26 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 166 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 65 | $0.00 |
| 90686 | 0% | 18 | $0.00 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 16 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 76 | $0.00 |
| 94799 | 0% | 42 | $0.00 | |
| 64643 | 0% | 268 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 55 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 13 | $0.00 |
| 93321 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALVEY, JENNIFER (SVP / CFO)
| Provider | Location | Paid |
|---|---|---|
| Indiana University Health, INC | Indianapolis, IN | $178.13M |
| Indiana University Health INC | Indianapolis, IN | $111.35M |
| Indiana University Health, INC | Indianapolis, IN | $4.54M |
| Indiana University Health, INC | Indianapolis, IN | $1.26M |
| Indiana University Health, INC | Indianapolis, IN | $556K |
| Indiana University Health, INC | Muncie, IN | $416K |
| Indiana University Health, INC | Carmel, IN | $415K |
| Indiana University Health, INC | Bloomington, IN | $339K |
| Indiana University Health, INC | Avon, IN | $326K |
| Indiana University Health, INC | Lafayette, IN | $262K |
| Indiana University Health, INC | Greenwood, IN | $92K |
| Indiana University Health INC. | Indianapolis, IN | $80K |
| Indiana University Health INC | Fishers, IN | $80K |
| Indiana University Health, INC | Indianapolis, IN | $28K |
| Indiana University Health, INC | Indianapolis, IN | $3K |
| Indiana University Health, INC | Indianapolis, IN | $81.39 |
| Indiana University Health INC | Indianapolis, IN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.